Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Public ClinicalTrials.gov record NCT01173874. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Study identification
- NCT ID
- NCT01173874
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- New York State Psychiatric Institute
- Other
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- Cognitive Remediation Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2010
- Primary completion
- Sep 30, 2013
- Completion
- Oct 31, 2013
- Last update posted
- Apr 10, 2017
2010 – 2013
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| San Fernando Mental Health Center | Granada Hills | California | 91344 | — |
| University of California - Irvine | Orange | California | 92868 | — |
| Yale University | New Haven | Connecticut | 06519 | — |
| University of Miami Department of Psychiatry | Miami | Florida | 33136 | — |
| Medical College of Georgia | Augusta | Georgia | 30912 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Rush University Psychiatric Clinical Research Center | Chicago | Illinois | 60612 | — |
| Indiana University | Indianapolis | Indiana | 46222 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02115 | — |
| University of Minnesota | Minneapolis | Minnesota | 55454 | — |
| University of Missouri | Columbia | Missouri | 65212 | — |
| Columbia University | New York | New York | 10032 | — |
| Psychopharmacology Research Unit- Nathan KIine Institute for Psychiatric Research | New York | New York | 10035 | — |
| Duke University Medical Center | Butner | North Carolina | 27509 | — |
| University of Texas Southwestern Medical Center at Dallas | Dallas | Texas | 75390 | — |
| University of Texas Health Science Center, San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01173874, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 10, 2017 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01173874 live on ClinicalTrials.gov.